Arteris (AIP) is back in focus after announcing an expanded partnership with Arm that embeds its Cycuity Radix hardware security tools more deeply into Arm’s next-generation CPU development flow.

The Arm partnership news comes after a sharp 11.54% 1 day share price return, even though the 30 day share price return is down 22.42%. At the same time, the 1 year total shareholder return of 262.50% and 3 year total shareholder return of about 3.7x highlight how strong longer term momentum has been.

If Arteris has you rethinking opportunities around AI hardware and infrastructure, it could be worth seeing what else is moving using the 54 AI infrastructure stocks

After Arteris jumped on the Arm partnership news, the stock still trades below the average analyst target and at a sizeable discount to one intrinsic value estimate. So where does a reasonable fair value range actually sit now?

Most Popular Narrative: 9.4% Undervalued

At a last close of $34.22 versus a most followed fair value estimate of $37.75, the prevailing Arteris narrative points to a modest undervaluation that leans heavily on future AI chip design demand.

Accelerating adoption of AI and machine learning in enterprise computing and automotive sectors is driving higher demand for Arteris' advanced NoC IP, as evidenced by recent major wins like AMD and Whalechip; this is likely to underpin sustained revenue growth as AI workloads and system complexity proliferate across industries.

Curious what sits behind that confidence in future revenue and cash flows? The most followed narrative leans on aggressive top line expansion, firmer margins, and a premium future earnings multiple that expects Arteris to behave more like a mature software platform rather than a loss making chip IP specialist.

Result: Fair Value of $37.75 (UNDERVALUED)

However, the Arteris story also carries clear pressure points, including ongoing net losses and a high dependence on a few large AI and data center customers.

Another View: What Multiples Say About Arteris

While the most followed fair value for Arteris sits at $37.75, the current pricing looks very different when viewed through its P/S ratio. At about 20.5x sales versus 3.6x for the US Software industry and 2.5x for peers, the stock trades well above both, and even above a fair ratio estimate of 7.3x that the market could move toward over time. Is the premium simply paying up for growth, or is it stretching what the business can reasonably deliver?

Next Steps

If the split opinion on Arteris has you on the fence, move quickly to review the full picture, including the 2 key rewards and 3 important warning signs

Looking for more investment ideas beyond Arteris?

If Arteris has sharpened your interest in AI and high growth stories, do not stop here. Broaden your watchlist with a few focused stock idea sets.

• Target potential mispricings by reviewing companies that screen as quality candidates on valuation and fundamentals using the 50 high quality undervalued stocks.
• Prioritize resilience by checking out companies that pass strict financial strength filters through the solid balance sheet and fundamentals stocks screener (48 results).
• Spot under-the-radar opportunities early by scanning the screener containing 20 high quality undiscovered gems before attention and capital move elsewhere.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.